Literature DB >> 34962077

Empirical likelihood confidence interval for sensitivity to the early disease stage.

Husneara Rahman1, Yichuan Zhao1.   

Abstract

Disease status can naturally be classified into three or more ordinal stages rather than just being binary stages. Many works have been done for the estimation and inference procedure regarding three ordinal disease stages, which are non-disease, early disease, and full disease stages. The early disease stage can be very important for therapeutic intervention and prevention potentiality. As a diagnostic measure, sensitivity to the early disease stage is often used. In this article, we propose confidence intervals for the sensitivity to early disease stage based on given target specificity for non-disease stage and target sensitivity to full disease stage using both empirical likelihood (EL) and adjusted EL procedures. We compare the performance of the proposed EL confidence intervals with other procedures in our simulation study. The proposed procedures are further applied to Alzheimer's Disease Neuroimaging Initiative data set.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  confidence interval; early disease stage; empirical likelihood; ordinal disease stages; sensitivity

Mesh:

Year:  2021        PMID: 34962077      PMCID: PMC9050820          DOI: 10.1002/pst.2186

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.234


  19 in total

1.  Parametric three-way receiver operating characteristic surface analysis using mathematica.

Authors:  P S Heckerling
Journal:  Med Decis Making       Date:  2001 Sep-Oct       Impact factor: 2.583

2.  Parametric and non-parametric confidence intervals of the probability of identifying early disease stage given sensitivity to full disease and specificity with three ordinal diagnostic groups.

Authors:  Tuochuan Dong; Lili Tian; Alan Hutson; Chengjie Xiong
Journal:  Stat Med       Date:  2011-12-05       Impact factor: 2.373

3.  Ordered multiple-class ROC analysis with continuous measurements.

Authors:  Christos T Nakas; Constantin T Yiannoutsos
Journal:  Stat Med       Date:  2004-11-30       Impact factor: 2.373

Review 4.  Exploring Biomarkers for Alzheimer's Disease.

Authors:  Neeti Sharma; Anshika Nikita Singh
Journal:  J Clin Diagn Res       Date:  2016-07-01

5.  Empirical likelihood-based confidence intervals for the sensitivity of a continuous-scale diagnostic test at a fixed level of specificity.

Authors:  Angela E Davis; Bing-Yi Jing
Journal:  Stat Methods Med Res       Date:  2009-08-04       Impact factor: 3.021

6.  Confidence interval estimation for sensitivity at a fixed level of specificity for combined biomarkers.

Authors:  Lili Tian
Journal:  J Biopharm Stat       Date:  2013-05       Impact factor: 1.051

Review 7.  Early recognition and prevention of chronic kidney disease.

Authors:  Matthew T James; Brenda R Hemmelgarn; Marcello Tonelli
Journal:  Lancet       Date:  2010-04-10       Impact factor: 79.321

8.  Estimating confidence intervals for the difference in diagnostic accuracy with three ordinal diagnostic categories without a gold standard.

Authors:  Le Kang; Chengjie Xiong; Lili Tian
Journal:  Comput Stat Data Anal       Date:  2013-12       Impact factor: 1.681

9.  Estimating diagnostic accuracy for clustered ordinal diagnostic groups in the three-class case-Application to the early diagnosis of Alzheimer disease.

Authors:  Chengjie Xiong; Jingqin Luo; Ling Chen; Feng Gao; Jingxia Liu; Guoqiao Wang; Randall Bateman; John C Morris
Journal:  Stat Methods Med Res       Date:  2017-11-28       Impact factor: 3.021

10.  DiagTest3Grp: An R Package for Analyzing Diagnostic Tests with Three Ordinal Groups.

Authors:  Jingqin Luo; Chengjie Xiong
Journal:  J Stat Softw       Date:  2012-09-22       Impact factor: 6.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.